Biocon Limited
BIOCON
Classement en actions
#3525
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Prix de l'action
$3.49
Capitalisation boursière
$4.77B
Changement (1 jour)
-5.05%
Changement (1 an)
-15.98%
Pays
IN
Échange Biocon Limited (BIOCON)
Catégorie
Healthcare
Historique du prix de l'action pour Biocon Limited (BIOCON)
Prix de clôture le plus élevé : $3.87 le 2026-10-01
Prix de clôture le plus bas : $1.16 le 2004-04-01
Prix de clôture le plus bas : $1.16 le 2004-04-01
Historique du prix de l'action de Biocon Limited de 2004 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -0.48% |
| 2025 | 3.10% |
| 2024 | 43.03% |
| 2023 | -9.84% |
| 2022 | -32.34% |
| 2021 | -21.74% |
| 2020 | 51.69% |
| 2019 | -7.50% |
| 2018 | 8.33% |
| 2017 | 76.96% |
| 2016 | 90.65% |
| 2015 | 2.58% |
| 2014 | 4.05% |
| 2013 | 29.61% |
| 2012 | -4.48% |
| 2011 | -38.93% |
| 2010 | 49.26% |
| 2009 | 165.57% |
| 2008 | -69.07% |
| 2007 | 80.35% |
| 2006 | -25.48% |
| 2005 | -5.27% |
| 2004 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
